4.6 Review

A 'time bomb' in the human intestine-the multiple emergence and spread of antibiotic-resistant bacteria

期刊

ENVIRONMENTAL MICROBIOLOGY
卷 24, 期 3, 页码 1231-1246

出版社

WILEY
DOI: 10.1111/1462-2920.15795

关键词

-

资金

  1. National Natural Science Foundation of China [31770087, 31970074, 32171424]

向作者/读者索取更多资源

The emergence of antibiotic-resistant bacteria (ARB) in the human intestine is mainly due to the excessive use of antibiotics, with antibiotic-resistant genes (ARGs) primarily spreading through the gut. Various methods are needed to prevent the emergence of ARB and inhibit the spread of ARGs in the human intestine, and ultimately, an interdisciplinary 'One Health' approach may be able to overcome this challenge.
Antibiotics have a strong killing effect on bacteria and are the first choice for the prevention and treatment of bacterial infectious diseases. Therefore, they have been widely used in the medical field, animal husbandry and planting industry. However, with the massive use of antibiotics, more and more antibiotic-resistant bacteria (ARB) have emerged. Because human intestines are rich in nutrients, have suitable temperature, and are high in bacterial abundance, they can easily become a hotbed for the spread of ARB and antibiotic-resistant genes (ARGs). When opportunistic pathogenic bacteria in the intestine acquire ARGs, the infectious diseases caused by such opportunistic pathogens will become more difficult to treat, or even impossible to cure. Therefore, ARB in the human intestine are like a 'time bomb'. In this review, we discuss the sources of intestinal ARB and the transmission routes of ARGs in the human intestine from the perspective of One Health. Further, we describe various methods to prevent the emergence of ARB and inhibit the spread of ARGs in the human intestine. Finally, we may be able to overcome ARB in the human intestine using an interdisciplinary 'One Health' approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据